ID   HAMT-1
AC   CVCL_D248
DR   Wikidata; Q54872406
RX   PubMed=2625822;
RX   PubMed=21597716;
CC   Group: Serum/protein free medium cell line.
CC   Population: Japanese.
CC   Doubling time: 18-20 hours (PubMed=2625822; PubMed=21597716).
CC   Derived from site: In situ; Urinary bladder; UBERON=UBERON_0001255.
DI   NCIt; C4912; Bladder carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   61Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 10
//
RX   PubMed=2625822; DOI=10.5980/jpnjurol1989.80.1749;
RA   Ito H., Yamaguchi K., Kotake T., Matsuzaki O.;
RT   "Primary culture of human bladder carcinomas and establishment of
RT   human bladder carcinoma cell line by serum-free culture.";
RL   Nihon Hinyokika Gakkai Zasshi 80:1749-1754(1989).
//
RX   PubMed=21597716; DOI=10.3892/or.2.2.221;
RA   Ito H., Kotake T., Masai M., Mizuta T., Adachi M.;
RT   "Establishment of human bladder-cancer cell-line (HAMT-1) and
RT   long-term subculture in nude-mice.";
RL   Oncol. Rep. 2:221-226(1995).
//